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Hepatitis C virus (HCV) infection has become a major cause of
iver diseases worldwide. Chronic HCV infection can induce seri-
us complications including cirrhosis and liver cancer.Distinct viral
enotypes responddifferently to antiviral treatment.Moreover, the
istribution of viral genotypes varies widely based on geographical
reas. HCV genotypes 1, 2 and 3 distribute worldwide. Genotype
(1a and 1b) is the most common genotype in the world and
as a high prevalence in the United States, Europe and East Asia.
enotype 2 can be found in Europe and America with a lower inci-
ence than Type 1 but is relatively common in Japan, China and
orea. The common genotype prevailing South Asia and Southeast
sia is genotype 3, especially 3a. Genotype 4 is prevalent in the
iddle East and the incidence seems to be increasing in Europe.
enotype 5 appears to be conﬁned to South Africa and Genotype
is found mostly in south China and Southeast Asia. In South-
ast Asia, each country demonstrates different HCV distribution.
hailand and Myanmar have a high rate of HCV-3a and 3b infec-
ion while HCV-6 variants are common in Vietnam, Laos, south
hina, Thailand, Myanmar and Cambodia. This genotype shows a
igh genetic diversity and new subtypes have been discovered con-
inually. HCV-6 is likely to be evolving in the endemic area and
preading to other regions by human migration. Surprisingly, HCV-
is not found in Malaysia and Indonesia. In Thailand, half of the
atients infected with HCV are caused by HCV 3a. The other HCV
ariants causing infection in Thailand are variants 1b, 3b, 6 and
arely genotype 2a. The introduction time to Thailand of HCV-3a
hich is closely related to the Indian strains has been estimated
y phylogenetic analysis and mathematics program to be approx-
mately 100 years ago. HCV-3a has become the major genotype
n this area as a result of a high incidence of illegal drug injec-
ion during the Vietnam War in the 1960s-1970s. The information
n HCV genotype distribution is useful for treatment recommen-
ations, surveillance and monitoring the incidence of HCV related
iseases.
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Background: Global dracunculiasis (Guinea worm disease)
eradication campaigns started in 1986, and the revised target
year for world wide eradication of the disease was 2009. Ethiopia
remains one of the four endemic countries of the world after erad-
ication campaigns of 17 years. Maintaining effective surveillance
is critical to detect all patients (100% contained) and stop trans-
mission for certiﬁcation. We analyzed surveillance reports from
1994-2011; to better understand the epidemiology of the disease
and recommend measures to interrupt transmission of disease.
Methods: All Guinea worm (GW) surveillance reports from
health facilities to the Ministry of Health. A GW patient is deﬁned
as an individual exhibiting or a history of a skin lesion with emer-
gence of one or more worms. Case containment is deﬁned as the
detection of a GW patient before the emergence of the worm to
prevent further transmission. Data of 18 years period (1994-2011)
were included and analyzed using Microsoft Excel.
Results: Cumulatively, 3521 patients were reported with mean
of 196 patients /year and range of 8-1252. A total of 127 (0.03%)
patients were imported from South Sudan. Equal number of males
and females were affected in 1996 and 2002, when 60% of 225
patients in 1996 and 82% of 39 patients in 2002 were 15–45 years
old. There was a year round transmission with the peak trans-
mission season April –July. The over all patient containment was
52% (1827/3521) and 48% (1694/3521) was not detected before
the emergence of worm. The annual incidence rate declined from
2.35 /100,000 in 1994 to 0.01/100,000 in 2011, and the prevalence
of the disease over 18 years period is 5.36/100,000. The number
of endemic villages and affected geographic areas paralleled that
decline.
Conclusion: Although the number of reported cases and trans-
mission has decreased signiﬁcantly, the struggle to stop the
transmission of the disease for certiﬁcation remains the challenge.
The low rate of containment portends continued transmission of
the disease. Effective surveillance is critical to detect all patients
(100% contained) beforemergence ofworm to prevent further local
transmission and for eventual certiﬁcation of its eradication.
http://dx.doi.org/10.1016/j.ijid.2012.05.087
